Literature DB >> 27371737

ErbB2: From an EGFR Relative to a Central Target for Cancer Therapy.

Nancy E Hynes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27371737     DOI： 10.1158/0008-5472.CAN-16-1356

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

1.  Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR.

Authors:  Julie K L Sinclair; Allison S Walker; Amy E Doerner; Alanna Schepartz
Journal:  Cell Chem Biol       Date:  2018-05-03       Impact factor: 8.116

Review 2.  Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.

Authors:  S Lheureux; C Denoyelle; P S Ohashi; J S De Bono; F M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-10       Impact factor: 9.236

3.  LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer.

Authors:  Qin Wang; Jiena Liu; Zilong You; Yanling Yin; Lei Liu; Yujuan Kang; Siwei Li; Shipeng Ning; Hui Li; Yajie Gong; Shouping Xu; Da Pang
Journal:  Cell Death Dis       Date:  2021-01-14       Impact factor: 8.469

4.  Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular Oncology.

Authors:  Bernd L Groner; Nancy E Hynes
Journal:  PLoS Biol       Date:  2016-09-29       Impact factor: 8.029
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.